Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Drugs for Short Bowel Syndrome market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Drugs for Short Bowel Syndromemarket, defines the market attractiveness level of Drugs for Short Bowel Syndrome market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Drugs for Short Bowel Syndrome industry, describes the types of Drugs for Short Bowel Syndrome market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drugs for Short Bowel Syndrome market and the development prospects and opportunities of Drugs for Short Bowel Syndrome industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drugs for Short Bowel Syndrome market in Chapter 13.
By Player:
Ardelyx
Zealand Pharma
Nutrinia
Sancilio Pharmaceuticals
Merck
Naia Pharmaceuticals
Takeda
Emmaus Medical
OxThera
By Type:
GLP-2
Growth Hormone
Glutamine
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Drugs for Short Bowel Syndrome Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Drugs for Short Bowel Syndrome Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Drugs for Short Bowel Syndrome Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Drugs for Short Bowel Syndrome Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Drugs for Short Bowel Syndrome Market Analysis and Outlook to 2022
-
7.1 Global Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
7.2 United States Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
7.3 Europe Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
7.4 China Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
7.5 Japan Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
7.6 India Drugs for Short Bowel Syndrome Consumption (2017-2022)
-
7.7 South Korea Drugs for Short Bowel Syndrome Consumption (2017-2022)
8 Region and Country-wise Drugs for Short Bowel Syndrome Market Analysis and Outlook to 2028
-
8.1 Global Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.2 United States Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.3 Europe Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.4 China Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.5 Japan Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.6 India Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
-
8.7 South Korea Drugs for Short Bowel Syndrome Consumption Forecast (2022-2028)
9 Global Drugs for Short Bowel Syndrome Market Outlook by Types and Applications to 2022
-
9.1 Global Drugs for Short Bowel Syndrome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global GLP-2 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glutamine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Drugs for Short Bowel Syndrome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Drugs for Short Bowel Syndrome Market Outlook by Types and Applications to 2028
-
10.1 Global Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global GLP-2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Drugs for Short Bowel Syndrome Import and Export Analysis (Top 5 Countries)
-
11.1 Global Drugs for Short Bowel Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Drugs for Short Bowel Syndrome Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Drugs for Short Bowel Syndrome Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Drugs for Short Bowel Syndrome Market Competitive Analysis
-
14.1 Ardelyx
-
14.1.1 Ardelyx Company Details
-
14.1.2 Ardelyx Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ardelyx Drugs for Short Bowel Syndrome Product and Service
-
14.2 Zealand Pharma
-
14.2.1 Zealand Pharma Company Details
-
14.2.2 Zealand Pharma Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zealand Pharma Drugs for Short Bowel Syndrome Product and Service
-
14.3 Nutrinia
-
14.3.1 Nutrinia Company Details
-
14.3.2 Nutrinia Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Nutrinia Drugs for Short Bowel Syndrome Product and Service
-
14.4 Sancilio Pharmaceuticals
-
14.4.1 Sancilio Pharmaceuticals Company Details
-
14.4.2 Sancilio Pharmaceuticals Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sancilio Pharmaceuticals Drugs for Short Bowel Syndrome Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Drugs for Short Bowel Syndrome Product and Service
-
14.6 Naia Pharmaceuticals
-
14.6.1 Naia Pharmaceuticals Company Details
-
14.6.2 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product and Service
-
14.7 Takeda
-
14.7.1 Takeda Company Details
-
14.7.2 Takeda Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Takeda Drugs for Short Bowel Syndrome Product and Service
-
14.8 Emmaus Medical
-
14.8.1 Emmaus Medical Company Details
-
14.8.2 Emmaus Medical Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Emmaus Medical Drugs for Short Bowel Syndrome Product and Service
-
14.9 OxThera
-
14.9.1 OxThera Company Details
-
14.9.2 OxThera Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 OxThera Drugs for Short Bowel Syndrome Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Drugs for Short Bowel Syndrome
-
Figure Drugs for Short Bowel Syndrome Picture
-
Table Global Drugs for Short Bowel Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Short Bowel Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Short Bowel Syndrome Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Drugs for Short Bowel Syndrome Consumption by Country (2017-2022)
-
Figure United States Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Table Europe Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure China Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Japan Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure India Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drugs for Short Bowel Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Short Bowel Syndrome Consumption Forecast by Country (2022-2028)
-
Figure United States Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drugs for Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GLP-2 Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global GLP-2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Drugs for Short Bowel Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Drugs for Short Bowel Syndrome Export by Region (Top 5 Countries) (2017-2028)
-
Table Ardelyx (Foundation Year, Company Profile and etc.)
-
Table Ardelyx Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ardelyx Drugs for Short Bowel Syndrome Product and Service
-
Table Zealand Pharma (Foundation Year, Company Profile and etc.)
-
Table Zealand Pharma Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zealand Pharma Drugs for Short Bowel Syndrome Product and Service
-
Table Nutrinia (Foundation Year, Company Profile and etc.)
-
Table Nutrinia Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nutrinia Drugs for Short Bowel Syndrome Product and Service
-
Table Sancilio Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sancilio Pharmaceuticals Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sancilio Pharmaceuticals Drugs for Short Bowel Syndrome Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Drugs for Short Bowel Syndrome Product and Service
-
Table Naia Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Naia Pharmaceuticals Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Drugs for Short Bowel Syndrome Product and Service
-
Table Emmaus Medical (Foundation Year, Company Profile and etc.)
-
Table Emmaus Medical Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emmaus Medical Drugs for Short Bowel Syndrome Product and Service
-
Table OxThera (Foundation Year, Company Profile and etc.)
-
Table OxThera Drugs for Short Bowel Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table OxThera Drugs for Short Bowel Syndrome Product and Service
-
